19.2 Weight and BMI Tracking Tracking anthropometric changes allows evaluation of metabolic improvement and therapy success
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
Persistent or worsening fatigue beyond several months warrants medical review to exclude anaemia, thyroid dysfunction, or other contributing conditions
Comprehensive psychological, ADHD, autism, and diagnostic-clarification evaluations performed by our licensed psychologists
Symptoms of hypoglycemia include dizziness, sweating, confusion, and weakness
In 2021, the most prescribed agents were semaglutide (about 680 per 100,000) and dulaglutide (about 790 per 100,000)